Immunomic Therapeutics
Developer of lysosomal-associated membrane protein (LAMP)-based vaccines designed to use immunotherapy to treat cancer, allergies, and animal health. The company's immunomodulation platform, LAMP-Vax,...
Valuation
$0
Share Price
N/A
Total Raised
$121.9M
Last Round
N/A